Rachel Waters

3.9k total citations · 1 hit paper
30 papers, 2.7k citations indexed

About

Rachel Waters is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Rachel Waters has authored 30 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 6 papers in Surgery. Recurrent topics in Rachel Waters's work include Cancer survivorship and care (5 papers), Childhood Cancer Survivors' Quality of Life (3 papers) and Bladder and Urothelial Cancer Treatments (3 papers). Rachel Waters is often cited by papers focused on Cancer survivorship and care (5 papers), Childhood Cancer Survivors' Quality of Life (3 papers) and Bladder and Urothelial Cancer Treatments (3 papers). Rachel Waters collaborates with scholars based in United Kingdom, Spain and United States. Rachel Waters's co-authors include Emma Hall, Douglas G. Altman, V Strong, Patrick Royston, Jane Walker, Susan Mallett, Susan Dutton, Lucy Wall, Michael Sharpe and Nicholas D. James and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

In The Last Decade

Rachel Waters

30 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Radiotherapy with or without Chemotherapy in Muscle-Invasive Bladder Cancer

2012 617 citations Nicholas D. James, Syed A. Hussain et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Rachel Waters

Since Specialization

Citations

This map shows the geographic impact of Rachel Waters's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel Waters with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel Waters more than expected).

Fields of papers citing papers by Rachel Waters

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel Waters. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel Waters. The network helps show where Rachel Waters may publish in the future.

Co-authorship network of co-authors of Rachel Waters

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel Waters. A scholar is included among the top collaborators of Rachel Waters based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel Waters. Rachel Waters is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Bland-Altman methods for comparing methods of measurement and response to criticisms 2020 ·SHILAP Revista de lepidopterología ·Mohammad Alì Mansournia, Rachel Waters, Maryam Nazemipour, Martin Bland, Douglas G. Altman	67
2	Latino Adolescent Perspectives Toward Sexually Transmitted Infection Educational Programs 2015 ·International Journal of Nursing Knowledge ·(unknown), Elizabeth Flórez, Karyn Holm, (unknown), Rachel Waters	5
3	A pilot study: dose adaptation of capecitabine using mobile phone toxicity monitoring — supporting patients in their homes 2014 ·Supportive Care in Cancer ·Andrew Weaver, Sharon Love, Mark Larsen, Milensu Shanyinde, Rachel Waters, (unknown), (unknown), Claire Brooks, Oliver Gibson, Annie Young, Lionel Tarassenko	23
4	Defining Bowel Dose Volume Constraints for Bladder Radiotherapy Treatment Planning 2014 ·Clinical Oncology ·Fiona McDonald, Rachel Waters, S. Gulliford, Emma Hall, Nicholas D. James, Robert Huddart	17
5	Validation and Reliability Testing of the EORTC QLQ-NMIBC24 Questionnaire Module to Assess Patient-reported Outcomes in Non–Muscle-invasive Bladder Cancer 2014 ·European Urology ·Jane Blazeby, Emma Hall, Neil K. Aaronson, Lisa K. Lloyd, Rachel Waters, John D. Kelly, Peter Fayers	63
6	Phase II trial of docetaxel, cisplatin and 5FU chemotherapy in locally advanced and metastatic penis cancer (CRUK/09/001) 2013 ·British Journal of Cancer ·Steve Nicholson, Emma Hall, S.J. Harland, John Chester, Lisa Pickering, J. Barber, Tony Elliott, Alastair Thomson, Stephanie Burnett, C. Cruickshank, Bernadette M. Carrington, Rachel Waters, Amit Bahl	84
7	Randomized Noninferiority Trial of Reduced High-Dose Volume Versus Standard Volume Radiation Therapy for Muscle-Invasive Bladder Cancer: Results of the BC2001 Trial (CRUK/01/004) 2013 ·International Journal of Radiation OncologyBiologyPhysics ·Robert Huddart, Emma Hall, Syed A. Hussain, Peter Jenkins, Christine Rawlings, Jean Tremlett, Malcolm Crundwell, F. Adab, Denise Sheehan, Isabel Syndikus, Carey Hendron, Rebecca Lewis, Rachel Waters, Nicholas D. James	97
8	Combining virotherapy and angiotherapy for the treatment of breast cancer 2013 ·Cancer Gene Therapy ·Miriam Bazán‐Peregrino, Richard C.A. Sainson, Robert Carlisle, Clemens Thoma, Rachel Waters, Costas Arvanitis, Adrian L. Harris, Rubén Hernández-Alcoceba, Leonard W. Seymour	23
9	Radiotherapy with or without Chemotherapy in Muscle-Invasive Bladder Cancer breakdown → 2012 ·New England Journal of Medicine ·Nicholas D. James, Syed A. Hussain, Emma Hall, Peter Jenkins, Jean Tremlett, Christine Rawlings, Malcolm Crundwell, Bruce Sizer, Thiagarajan Sreenivasan, Carey Hendron, Rebecca Lewis, Rachel Waters, Robert Huddart	617
10	Serum selenium concentration at diagnosis and outcome in patients with haematological malignancies 2011 ·British Journal of Haematology ·Jane Stevens, Rachel Waters, (unknown), Shireen Kassam, Silvia Montoto, Jude Fitzgibbon, A. Z. S. Rohatiner, Andrew Lister, Simon Joel	17
11	Effect of mitoxantrone on outcome of children with first relapse of acute lymphoblastic leukaemia (ALL R3): an open-label randomised trial 2010 ·The Lancet ·Catriona Parker, Rachel Waters, (unknown), Jeremy Hancock, Rosemary Sutton, Anthony V. Moorman, Philip Ancliff, Mary Morgan, Ashish Masurekar, Nicholas Goulden, (unknown), Tamás Révész, Philip Darbyshire, Sharon Love, Vaskar Saha	229
12	Reporting performance of prognostic models in cancer: a review 2010 ·BMC Medicine ·Susan Mallett, Patrick Royston, Rachel Waters, Susan Dutton, Douglas G. Altman	145
13	Reporting methods in studies developing prognostic models in cancer: a review 2010 ·BMC Medicine ·Susan Mallett, Patrick Royston, Susan Dutton, Rachel Waters, Douglas G. Altman	155
14	Predicting the myelotoxicity of chemotherapy 2010 ·Melanoma Research ·Ami Sabharwal, Rachel Waters, Sarah Danson, Andrew R. Clamp, Paul Lorigan, Nick Thatcher, Geoffrey P. Margison, Mark R. Middleton	18
15	Cytoplasmic β‐catenin accumulation is a good prognostic marker in upper and lower gastrointestinal adenocarcinomas 2010 ·Histopathology ·(unknown), Neil A. Bailey, Manoj Nanji, Richard Gillies, Anna M. Nicholson, (unknown), (unknown), Richard Steyn, Chris Womack, Alun D. Hughes, David Hemingway, Rebecca Harrison, Rachel Waters, Janusz Jankowski	14
16	Mobile phone technology for managing chemotherapy associated side-effects 2008 ·Oncology nursing forum ·A. J. Young, Lionel Tarassenko, Andrew Weaver, Rachel Waters, Joshua Smith, (unknown), Deborah A. Kerr	1
17	Virotherapy expressing regulatory angiogenic gene therapy in treatment of breast cancer 2008 ·Human Gene Therapy ·Miriam Bazán‐Peregrino, Richard C.A. Sainson, Robert Carlisle, Rachel Waters, Adrian L. Harris, Rubén Hernández-Alcoceba, Leonard W. Seymour	1
18	Risk and Clinical Implications of Transformation of Follicular Lymphoma to Diffuse Large B-Cell Lymphoma 2007 ·Journal of Clinical Oncology ·Silvia Montoto, Andrew Davies, Janet Matthews, Maria Calaminici, A. J. Norton, John Amess, Sarah Vinnicombe, Rachel Waters, A. Z. S. Rohatiner, T. Andrew Lister	279
19	Clinically relevant fatigue in cancer outpatients: the Edinburgh Cancer Centre symptom study 2007 ·Annals of Oncology ·D. Storey, Rachel Waters, C. Hibberd, R. W. RUSH, (unknown), Lucy Wall, Marie Fallon, V Strong, Jane Walker, Michael Sharpe	54
20	Morphea of the breast. Two case reports and discussion of the literature 2006 ·Journal of Plastic Reconstructive & Aesthetic Surgery ·Anne Dancey, Rachel Waters	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact